chr7-14226591-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001350709.2(DGKB):c.2123-48440T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00478 in 152,156 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.0048   (  14   hom.,  cov: 32) 
Consequence
 DGKB
NM_001350709.2 intron
NM_001350709.2 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  1.26  
Publications
1 publications found 
Genes affected
 DGKB  (HGNC:2850):  (diacylglycerol kinase beta) Diacylglycerol kinases (DGKs) are regulators of the intracellular concentration of the second messenger diacylglycerol (DAG) and thus play a key role in cellular processes. Nine mammalian isotypes have been identified, which are encoded by separate genes. Mammalian DGK isozymes contain a conserved catalytic (kinase) domain and a cysteine-rich domain (CRD). The protein encoded by this gene is a diacylglycerol kinase, beta isotype. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0642  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| DGKB | NM_001350709.2 | c.2123-48440T>C | intron_variant | Intron 23 of 25 | ENST00000402815.6 | NP_001337638.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.00475  AC: 722AN: 152038Hom.:  14  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
722
AN: 
152038
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.00478  AC: 727AN: 152156Hom.:  14  Cov.: 32 AF XY:  0.00547  AC XY: 407AN XY: 74384 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
727
AN: 
152156
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
407
AN XY: 
74384
show subpopulations 
African (AFR) 
 AF: 
AC: 
61
AN: 
41568
American (AMR) 
 AF: 
AC: 
246
AN: 
15260
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
361
AN: 
5146
South Asian (SAS) 
 AF: 
AC: 
11
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
17
AN: 
10608
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
21
AN: 
67956
Other (OTH) 
 AF: 
AC: 
9
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 37 
 73 
 110 
 146 
 183 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
92
AN: 
3438
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.